The global market for Lung Disease Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Lung Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Disease Therapeutics.

The Lung Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Disease Therapeutics Market Report

Report Metric	Details
Report Name	Lung Disease Therapeutics Market
CAGR	5%
Segment by Type	Asthma Chronic Obstructive Pulmonary Disease (COPD) Lung Cancer Other Lung Diseases
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals, Cipla, Fibrogen, Liminal Biosciences, PharmAkea Therapeutics, IQVIA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lung Disease Therapeutics Market report?

Ans: The main players in the Lung Disease Therapeutics Market are GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals, Cipla, Fibrogen, Liminal Biosciences, PharmAkea Therapeutics, IQVIA

What are the Application segmentation covered in the Lung Disease Therapeutics Market report?

Ans: The Applications covered in the Lung Disease Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Lung Disease Therapeutics Market report?

Ans: The Types covered in the Lung Disease Therapeutics Market report are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Other Lung Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Asthma

1.2.3 Chronic Obstructive Pulmonary Disease (COPD)

1.2.4 Lung Cancer

1.2.5 Other Lung Diseases

1.3 Market by Application

1.3.1 Global Lung Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Disease Therapeutics Market Perspective (2020-2031)

2.2 Global Lung Disease Therapeutics Growth Trends by Region

2.2.1 Global Lung Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lung Disease Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Lung Disease Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Lung Disease Therapeutics Market Dynamics

2.3.1 Lung Disease Therapeutics Industry Trends

2.3.2 Lung Disease Therapeutics Market Drivers

2.3.3 Lung Disease Therapeutics Market Challenges

2.3.4 Lung Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Disease Therapeutics Players by Revenue

3.1.1 Global Top Lung Disease Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Lung Disease Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Lung Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lung Disease Therapeutics Revenue

3.4 Global Lung Disease Therapeutics Market Concentration Ratio

3.4.1 Global Lung Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Disease Therapeutics Revenue in 2024

3.5 Global Key Players of Lung Disease Therapeutics Head office and Area Served

3.6 Global Key Players of Lung Disease Therapeutics, Product and Application

3.7 Global Key Players of Lung Disease Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Disease Therapeutics Breakdown Data by Type

4.1 Global Lung Disease Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Lung Disease Therapeutics Forecasted Market Size by Type (2026-2031)

5 Lung Disease Therapeutics Breakdown Data by Application

5.1 Global Lung Disease Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Lung Disease Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lung Disease Therapeutics Market Size (2020-2031)

6.2 North America Lung Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lung Disease Therapeutics Market Size by Country (2020-2025)

6.4 North America Lung Disease Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Disease Therapeutics Market Size (2020-2031)

7.2 Europe Lung Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lung Disease Therapeutics Market Size by Country (2020-2025)

7.4 Europe Lung Disease Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Disease Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Lung Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lung Disease Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Lung Disease Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Disease Therapeutics Market Size (2020-2031)

9.2 Latin America Lung Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lung Disease Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Lung Disease Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Disease Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Lung Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lung Disease Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Lung Disease Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Lung Disease Therapeutics Introduction

11.1.4 GSK Revenue in Lung Disease Therapeutics Business (2020-2025)

11.1.5 GSK Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Lung Disease Therapeutics Introduction

11.2.4 AstraZeneca Revenue in Lung Disease Therapeutics Business (2020-2025)

11.2.5 AstraZeneca Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Lung Disease Therapeutics Introduction

11.3.4 Boehringer Ingelheim Revenue in Lung Disease Therapeutics Business (2020-2025)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Lung Disease Therapeutics Introduction

11.4.4 Novartis Revenue in Lung Disease Therapeutics Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Mylan

11.5.1 Mylan Company Details

11.5.2 Mylan Business Overview

11.5.3 Mylan Lung Disease Therapeutics Introduction

11.5.4 Mylan Revenue in Lung Disease Therapeutics Business (2020-2025)

11.5.5 Mylan Recent Development

11.6 Vertex Pharmaceuticals

11.6.1 Vertex Pharmaceuticals Company Details

11.6.2 Vertex Pharmaceuticals Business Overview

11.6.3 Vertex Pharmaceuticals Lung Disease Therapeutics Introduction

11.6.4 Vertex Pharmaceuticals Revenue in Lung Disease Therapeutics Business (2020-2025)

11.6.5 Vertex Pharmaceuticals Recent Development

11.7 F. Hoffman La Roche

11.7.1 F. Hoffman La Roche Company Details

11.7.2 F. Hoffman La Roche Business Overview

11.7.3 F. Hoffman La Roche Lung Disease Therapeutics Introduction

11.7.4 F. Hoffman La Roche Revenue in Lung Disease Therapeutics Business (2020-2025)

11.7.5 F. Hoffman La Roche Recent Development

11.8 Teva Pharmaceuticals

11.8.1 Teva Pharmaceuticals Company Details

11.8.2 Teva Pharmaceuticals Business Overview

11.8.3 Teva Pharmaceuticals Lung Disease Therapeutics Introduction

11.8.4 Teva Pharmaceuticals Revenue in Lung Disease Therapeutics Business (2020-2025)

11.8.5 Teva Pharmaceuticals Recent Development

11.9 Cipla

11.9.1 Cipla Company Details

11.9.2 Cipla Business Overview

11.9.3 Cipla Lung Disease Therapeutics Introduction

11.9.4 Cipla Revenue in Lung Disease Therapeutics Business (2020-2025)

11.9.5 Cipla Recent Development

11.10 Fibrogen

11.10.1 Fibrogen Company Details

11.10.2 Fibrogen Business Overview

11.10.3 Fibrogen Lung Disease Therapeutics Introduction

11.10.4 Fibrogen Revenue in Lung Disease Therapeutics Business (2020-2025)

11.10.5 Fibrogen Recent Development

11.11 Liminal Biosciences

11.11.1 Liminal Biosciences Company Details

11.11.2 Liminal Biosciences Business Overview

11.11.3 Liminal Biosciences Lung Disease Therapeutics Introduction

11.11.4 Liminal Biosciences Revenue in Lung Disease Therapeutics Business (2020-2025)

11.11.5 Liminal Biosciences Recent Development

11.12 PharmAkea Therapeutics

11.12.1 PharmAkea Therapeutics Company Details

11.12.2 PharmAkea Therapeutics Business Overview

11.12.3 PharmAkea Therapeutics Lung Disease Therapeutics Introduction

11.12.4 PharmAkea Therapeutics Revenue in Lung Disease Therapeutics Business (2020-2025)

11.12.5 PharmAkea Therapeutics Recent Development

11.13 IQVIA

11.13.1 IQVIA Company Details

11.13.2 IQVIA Business Overview

11.13.3 IQVIA Lung Disease Therapeutics Introduction

11.13.4 IQVIA Revenue in Lung Disease Therapeutics Business (2020-2025)

11.13.5 IQVIA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Vertex Pharmaceuticals

PharmAkea Therapeutics

IQVIA

GSK

List of Tables

Table 1. Global Lung Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Asthma

Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Other Lung Diseases

Table 6. Global Lung Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Lung Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Lung Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Lung Disease Therapeutics Market Share by Region (2020-2025)

Table 10. Global Lung Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Lung Disease Therapeutics Market Share by Region (2026-2031)

Table 12. Lung Disease Therapeutics Market Trends

Table 13. Lung Disease Therapeutics Market Drivers

Table 14. Lung Disease Therapeutics Market Challenges

Table 15. Lung Disease Therapeutics Market Restraints

Table 16. Global Lung Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Lung Disease Therapeutics Market Share by Players (2020-2025)

Table 18. Global Top Lung Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutics as of 2024)

Table 19. Ranking of Global Top Lung Disease Therapeutics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Lung Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Lung Disease Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Lung Disease Therapeutics, Product and Application

Table 23. Global Key Players of Lung Disease Therapeutics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Lung Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Lung Disease Therapeutics Revenue Market Share by Type (2020-2025)

Table 27. Global Lung Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Lung Disease Therapeutics Revenue Market Share by Type (2026-2031)

Table 29. Global Lung Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Lung Disease Therapeutics Revenue Market Share by Application (2020-2025)

Table 31. Global Lung Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Lung Disease Therapeutics Revenue Market Share by Application (2026-2031)

Table 33. North America Lung Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Lung Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Lung Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Lung Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Lung Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Lung Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Lung Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Lung Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Lung Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Lung Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Lung Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Lung Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Lung Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Lung Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Lung Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. GSK Company Details

Table 49. GSK Business Overview

Table 50. GSK Lung Disease Therapeutics Product

Table 51. GSK Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 52. GSK Recent Development

Table 53. AstraZeneca Company Details

Table 54. AstraZeneca Business Overview

Table 55. AstraZeneca Lung Disease Therapeutics Product

Table 56. AstraZeneca Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 57. AstraZeneca Recent Development

Table 58. Boehringer Ingelheim Company Details

Table 59. Boehringer Ingelheim Business Overview

Table 60. Boehringer Ingelheim Lung Disease Therapeutics Product

Table 61. Boehringer Ingelheim Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 62. Boehringer Ingelheim Recent Development

Table 63. Novartis Company Details

Table 64. Novartis Business Overview

Table 65. Novartis Lung Disease Therapeutics Product

Table 66. Novartis Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 67. Novartis Recent Development

Table 68. Mylan Company Details

Table 69. Mylan Business Overview

Table 70. Mylan Lung Disease Therapeutics Product

Table 71. Mylan Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 72. Mylan Recent Development

Table 73. Vertex Pharmaceuticals Company Details

Table 74. Vertex Pharmaceuticals Business Overview

Table 75. Vertex Pharmaceuticals Lung Disease Therapeutics Product

Table 76. Vertex Pharmaceuticals Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 77. Vertex Pharmaceuticals Recent Development

Table 78. F. Hoffman La Roche Company Details

Table 79. F. Hoffman La Roche Business Overview

Table 80. F. Hoffman La Roche Lung Disease Therapeutics Product

Table 81. F. Hoffman La Roche Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 82. F. Hoffman La Roche Recent Development

Table 83. Teva Pharmaceuticals Company Details

Table 84. Teva Pharmaceuticals Business Overview

Table 85. Teva Pharmaceuticals Lung Disease Therapeutics Product

Table 86. Teva Pharmaceuticals Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 87. Teva Pharmaceuticals Recent Development

Table 88. Cipla Company Details

Table 89. Cipla Business Overview

Table 90. Cipla Lung Disease Therapeutics Product

Table 91. Cipla Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 92. Cipla Recent Development

Table 93. Fibrogen Company Details

Table 94. Fibrogen Business Overview

Table 95. Fibrogen Lung Disease Therapeutics Product

Table 96. Fibrogen Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 97. Fibrogen Recent Development

Table 98. Liminal Biosciences Company Details

Table 99. Liminal Biosciences Business Overview

Table 100. Liminal Biosciences Lung Disease Therapeutics Product

Table 101. Liminal Biosciences Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 102. Liminal Biosciences Recent Development

Table 103. PharmAkea Therapeutics Company Details

Table 104. PharmAkea Therapeutics Business Overview

Table 105. PharmAkea Therapeutics Lung Disease Therapeutics Product

Table 106. PharmAkea Therapeutics Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 107. PharmAkea Therapeutics Recent Development

Table 108. IQVIA Company Details

Table 109. IQVIA Business Overview

Table 110. IQVIA Lung Disease Therapeutics Product

Table 111. IQVIA Revenue in Lung Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 112. IQVIA Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Lung Disease Therapeutics Picture

Figure 2. Global Lung Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lung Disease Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Asthma Features

Figure 5. Chronic Obstructive Pulmonary Disease (COPD) Features

Figure 6. Lung Cancer Features

Figure 7. Other Lung Diseases Features

Figure 8. Global Lung Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Lung Disease Therapeutics Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Lung Disease Therapeutics Report Years Considered

Figure 14. Global Lung Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Lung Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Lung Disease Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Lung Disease Therapeutics Market Share by Players in 2024

Figure 18. Global Top Lung Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Lung Disease Therapeutics Revenue in 2024

Figure 20. North America Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Lung Disease Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Lung Disease Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Lung Disease Therapeutics Market Share by Region (2020-2031)

Figure 34. China Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Lung Disease Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Lung Disease Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Lung Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. GSK Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 50. AstraZeneca Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 51. Boehringer Ingelheim Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 53. Mylan Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 54. Vertex Pharmaceuticals Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 55. F. Hoffman La Roche Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 57. Cipla Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 58. Fibrogen Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 59. Liminal Biosciences Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 60. PharmAkea Therapeutics Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 61. IQVIA Revenue Growth Rate in Lung Disease Therapeutics Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Obstructive Pulmonary Disease Therapeutics Market Research Report 2024

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Obstructive Pulmonary Disease Clinical Therapeutics Market Research Report 2025

Heart and Lung Therapy System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pediatric Respiratory Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Respiratory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Research Report 2025

Acute Lung Injury Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions